The Patent Finder
US

VEGF Antagonist Formulations for Intravitreal Administration

US 8,481,046 In force
OverviewFamilyAssignmentsSources & methods

Term ends Jun 14, 2027 · High confidence

Filed Dec 19, 2011 as application 13/329,770 · Granted Jul 9, 2013
Base term, 20 years from filing
Today
20 years from filing
2007 2027
Clock starts
Jun 14, 2007
Term ends
Jun 14, 2027
Granted
Jul 9, 2013
base term fee events Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
16
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jun 14, 2007, when application 11/818,463, the earliest non-provisional in its chain, was filed (this one was filed Dec 19, 2011)Jun 14, 2027High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJun 14, 2027High confidence

This family

US 7,608,261In force
no later than Jul 2027
no later than Jul 2027
US 7,807,164In force
Jun 2027
Jun 2027
US 8,092,803In force
Jun 2027
Jun 2027
US 8,481,046this patent
Jun 2027
Jun 2027
US 8,802,107In force
Jun 2027
Jun 2027
US 9,340,594In force
Jun 2027
Jun 2027
US 9,914,763Lapsed on the fee record
Mar 2026
Mar 2026
US 9,580,489Term ended
Mar 2021
Mar 2021
8 of 16 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Apr 7, 2014
Reel 32616, frame 301
Furfine, Eric; Dix, Daniel B; Graham, Kenneth S; Frye, KellyRegeneron Pharmaceuticals, Inc.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited